**Strong word-of-mouth and critical acclaim from its surprise breakout opening have positioned A24’s three-hour Elizabeth Holmes documentary for robust theatrical legs through November 30.** Released October 16 in 855 theaters, the Nathan Fielder–Lance Oppenheim film opened to $15.6 million—roughly double pre-release tracking—delivering the largest non-concert documentary debut in over a decade and the biggest per-screen average for a limited release since Borat. Near-universal reviews (97–99 Metacritic/RT) and 99% audience scores, plus over 2,000 sellouts and strong under-35 turnout, have driven consistent daily holds and midweek chart dominance, pushing the domestic cume past $25 million in its first week. Expansion to roughly 2,600 screens for the second weekend, with $20–25 million projections, supplies the next major catalyst. Traders see the combination of low budget, sustained cultural conversation around the Theranos saga, and proven audience appetite supporting totals clustering in the $125–175 million range by month’s end, though typical documentary drop-off patterns remain a modest risk factor.